Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Date:11/3/2010

ns

142376186310Dilutive effect of convertible senior notes (4)5,8015,801-5,801Non-GAAP diluted shares (3)68,65066,42562,74864,312Non-GAAP net income per share (3)$
.88$
.37$
.91$
.78Non-GAAP net income per share - diluted (3) $
.84$
.35$
.90$
.73(3)
This press release includes the following non-GAAP financial measures: non-GAAP net income, non-GAAP net income – diluted, non-GAAP net income per share, and non-GAAP net income per share – diluted. The foregoing table reconciles these non-GAAP measures to the most comparable financial measures calculated in accordance with GAAP.Onyx management uses these non-GAAP financial measures to monitor and evaluate our operating results and trends on an on-going basis and internally for operating, budgeting and financial planning purposes. Onyx management believes the non-GAAP information is useful for investors by offering them the ability to better identify trends in our business and better understand how management evaluates the business. These non-GAAP measures have limitations, however, because they do not include all items of income and expense that affect Onyx. These non-GAAP financial measures that management uses are not prepared in accordance with, and should not be considered in isolation of, or an as alternative to, measurements required by GAAP.These non-GAAP financial measures exclude the following items from GAAP net income (loss) and diluted per share amounts:Contingent consideration expense
: The effects of contingent consideration expense are excluded due to the nature of this charge, which is related to the change in fair value of the liability for contingent consideration in connection with the acquisition of Proteolix; such exclusion facilitates comparisons of Onyx's operating results to peer companies.Employee stock-based compensation
: The effects of employee stock-based compensation are excluded because of varying available valuation m
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
2. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
3. Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010
4. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
5. ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
8. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
9. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
10. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... July 7, 2015 Berger & Montague, ... litigation law firm with one of the largest ... joined co-counsel Faruqi and Faruqi, LLP in settling ... manufacturers AstraZeneca Pharmaceuticals LP, Cephalon, Inc., and Biogen, ... statutory fees.  Under the agreements, AstraZeneca will pay ...
(Date:7/7/2015)... 7, 2015 Sequent Medical, a privately ... devices for the treatment of neurovascular disease, announced ... joined its Board of Directors.   ... device and healthcare industries experience.  He has successfully ... commercialized numerous leading-edge products.  His experience encompasses a ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... BIRMINGHAM, Ala., Jan. 23 BioCryst,Pharmaceuticals, Inc. ... update on activities,conducted following release of the ... clinical development plan for intramuscular (i.m.) peramivir., ... Following release of preliminary Phase II results ...
... This Month ... at the University of Kentucky, LEXINGTON, Ky., ... on Aging are launching an Alzheimer,s,screening clinical trial with Neuronetrix,s ... assessments,using a technology called event-related potentials (ERP,s). The study is,expected ...
Cached Medicine Technology:BioCryst Updates Peramivir Clinical Development Plan 2BioCryst Updates Peramivir Clinical Development Plan 3BioCryst Updates Peramivir Clinical Development Plan 4BioCryst Updates Peramivir Clinical Development Plan 5BioCryst Updates Peramivir Clinical Development Plan 6Innovative Brain Scanning for Alzheimer's Screening Unveiled 2
(Date:7/7/2015)... ... July 07, 2015 , ... Catalent, ... development solutions for drugs, biologics and consumer health products, today announced that ... its antibody combination therapy (ACT) technology platform. The platform has the potential ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... Safe ... tests every single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts ... canned tuna. , “We developed the technology to test every fish for mercury,” said ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, the Manistee, ... Golf and Country Club. Best Drug Rehabilitation staff members were delighted to join in ... children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a global organization ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... of Downtown Detroit was the site of the National Baptist Convention 110th Annual ... Focusing on encouraging and promoting the collaboration of churches and their congregations, medical ...
Breaking Medicine News(10 mins):Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... 20,000 newborns are shocked to learn their child has type ... disorder. Although doctors know that babies inherit CDM1 from ... not diagnosed until they are born. ,In these instances, ... (DM1) a common form of muscular dystrophy because ...
... When actress Sally Field was diagnosed with osteoporosis in 2005, ... eaten right, I had always exercised, and I had always ... tried to be a good girl all the way down ... ,Field was in town to talk to legislators at ...
... its death dance continues unabated in the region. What little ... people. ,Africa has increased the number of ... million last year, but a lack of medical workers is ... released Thursday by Medecins Sans Frontieres. ,"The international ...
... for money to pay for badly needed restorations, are reaching ... dog parades, bird-watching lectures, Sunday jazz concerts, brunches with ... nudie calendar. ,The cemetery tourism fever is catching ... supper aboard the Titanic made many gasp for breath. It ...
... Jerusalem says that he has observed the real time generation ... of such kind in the world. ... Institute of Life Sciences, used mouse models to study how ... and complex cell. ,The new findings are significant ...
... a cocktail of enzymes that converts starchy syrups into carbon ... a fuel cell to run an electric car, or ... ,The method hinges on a mixture of 13 enzymes, normally ... together in nature. ,According to Y-H Percival ...
Cached Medicine News:Health News:Researcher Studying Disease That Cripples Newborns 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 3Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 2Health News:Shortage of Doctors and Nurses Affects AIDS Treatment in Africa 3Health News:Cemetery Tourism, the New Catchword in US 2Health News:Scientist Observes real Time Generation of Neurones in Mammals 2Health News:Researchers Discover Starch Cocktail Fuel for green Car 2
Inquire...
Compact tray features all components for urethral catheterization....
Inquire...
Provides maximum comfort upon insertion through ultra-smooth catheter eyelets--formed with advanced ultrasonic technology....
Medicine Products: